Formulation and In Vitro Evaluation of Araucaria bidwilli Gum-Based Sustain Release Matrix Tablets of Diclofenae Sodium


  • PRIST University, Thanjavur, Tamil Nadu, 614 904, India
  • JSS college of Pharmacy, Department of Pharmaceutics, Ooty, Tamil Nadu, 643001, India
  • Mother Theresa Institute of Health Sciences, Puducherry, 605006, India


A gel forming Polysaccharide gum obtained form the bark of Araucaria bidwilli was employed as a matrix sustained release tablet formulation of Diclofenac sodium (a non steroidal anti inflammatory agent). The effect of Araucaria bidwilli gum ( Natural ) and Synthetic polymer Hydroxypropyl methyl cellulose ( HPM C K4 M ) on the release of Diclofenac sodium was studied. The FT - IR spectroscopic studies of drug, gum and mixture indicated no chemical interaction . Six formulations were prepared by wet granulation method containing Araucaria bidwilli gum pow der concentration 10 % 20 % & 30 % w \ w and 10 % 20% &30% w \ w of HPMC K4M with sufficient volume of granulating agent Polyvinyl pyrrolene (PVP K 30) , Avicel pH101 as diluents , Magnesium stearate and Aero silis used lubricant and glidant respectively . This study was carried out to find out the difference between synthetic and natural gum and whether synthetic gum can be replaced by natural gums. Physical and techno logical studies of granules and tablets were compliance with Pharmacopoial standards . The drug release increased with Araucaria bidwilli gum when compared to synthetics polymer concentration. The value of release exponent were found to be almost straight line and regression coefficient value between 0. 9 38 and 0. 99 8 . This implies that the release mechanism is diffusion. Formulation F3 (contained 30% w \ w Araucaria bidwilli gum) met the desired requirements for a sustained release dosage form.


Diclofenac sodium, Araucaria bidwilli, HPMC K4 M, Wet Granulation, Sustained Release.

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Pawar H, Dmello P.M. Isolation of seed gum from cassia tora and preliminary studies of its application as a binder for tablets. Indian Drugs August 2004; 41(8): 465- 468

Haines R.J. Embryo development and anatomy in Araucaria Juss.Australian journal of botany 1983;31:125140.

Haines R.J. Seed development in Araucaria Juss.Australian journal of botany 1983;31: 255-267

Munday D.L and Cox P.J. Int. Journal of Pharm.2000;200:179

Nochodchi A,Farid D.J, Najdfi M and Adrangui M. Drug develop.Ind.Pharm,1997;23:1019

Gangurta A.B. To evaluate gum of Azadirachta indica (Neem) as a binder for Pharmaceutical dosage forms. IJPER 2008; 344

Baveja S.K, Ranga Rao K.V and Arora J. Indian journal of pharm.sci. 1-8-; 51:115

Indian Pharmacopoeia. Vol II, Ministry of health and family welfare, Govt of India, New Delhi,1985;A-73,A-88

Panda D.S. To find out the potential of gum from Moringa olifera to act as a binder and release retardant in tablet formulation. Research paper 2008;70: 614-618

Gobel M.C, Jogani P.D and Bariya S.H. Development of agglomerated directly compressible diluent consisting of brittle and ductile materials. Pharm.Dev.Tech.,2003:(2)8:143-151

Talukdar M.M , Vinekier I, Modenaer P and Kinget R. Rheological characterization of Xanthan gum and hydroxypropyl methyl cellulose with respect to cotrolled release drug delivery. J.Pharm.sci 1996; 85:537-540

Subrahmanyam C.V.S. Text book of Physical Pharmaceutics. 2nd edi. Vallabh prakashan. New Delki 2000;226-228

Gordon R.E, Rashanke T.W, Fonner D.E,Anderson N.R and Banker G.S In: Lachman L,Liberman H.H,Schwartz J.B. Pharmaceutical dosage forms:Tablets vol. 2,Marcel Dekker,Newyork 1999; 245-335

USP 23/NF 18, United State Pharmacopoeial convention Inc , Rockville M.D . Asian Edi, 1995;1041

Lachman L, Liberman H.A and Kanig J.L. The theory and practice of industrial pharmacy,3 rd edi. Varghese publishing house,Mumbai. 1987;88

Talukdar M.M and Kinget R. Swelling and drug release behavior of Xantham gum matrixtablets. Int. J.Pharm. 1995;120: 63-72

Srisagul Sungthongjeen ,Ornlaksana Paeratakul, Santaya Limmatvapirat. Preparation and invitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.International journal of Pharmaceutics 2006;324:136-143

Talukdar M.M , Michoel A , Rombaut P and Kinget R. Comparitive study on Xanthan gum and hydroxypropyl methyl cellulose as matrices for controlled release drug delivery. I. Compartion and invitro drug release behaviour. Int.J.Pharm. 1996; 120: 231-241

United States Pharmacopoeia.25 th ed NF 20: United States Pharmacopoeial convention,Inc,Rockville:2002,1142

Wagner J.G Interpretation of percent dissolved from invitro testing of conventional tablets and capsules J.Pharm.Sci.1969; 58:1253-1257

Hguchi T. Mechanism of sustained action medication theoretical analysis of rate release of solid drug dispersed in solid matrices. J. Pharm.sci. 1963; 52:1145-1140

Peppas N.A. Analysis of Fickian and non Fickian drug release from polymer.Pharm. Acta Heln . 1985;60:110-111

Harland R.S, Gazzaniga A, Sangali M.E, Colombo P,Peppas N.A. Drug/ Polymer matrix swelling and dissolution. Pharma. Res.1988;5:488-404


  • There are currently no refbacks.